{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:58:33Z","timestamp":1789790313500,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["20131610101840"],"award-info":[{"award-number":["20131610101840"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12964-019-0322-x","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T05:04:06Z","timestamp":1550034246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Low dose radiation regulates BRAF-induced thyroid cellular dysfunction and transformation"],"prefix":"10.1186","volume":"17","author":[{"given":"Neha","family":"Kaushik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagendra Kumar","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Kyung","family":"Myung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyeok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk-Jin","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cha-Soon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Young","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"322_CR1","first-page":"6997","volume":"62","author":"MS Brose","year":"2002","unstructured":"Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R, Einhorn E, Herlyn M, Minna J, Nicholson A, et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 2002;62:6997\u20137000.","journal-title":"Cancer Res"},{"key":"322_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949\u201354.","journal-title":"Nature"},{"key":"322_CR3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/418934a","volume":"418","author":"H Rajagopalan","year":"2002","unstructured":"Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. Tumorigenesis: RAF\/RAS oncogenes and mismatch-repair status. Nature. 2002;418:934.","journal-title":"Nature"},{"key":"322_CR4","first-page":"6451","volume":"62","author":"ST Yuen","year":"2002","unstructured":"Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, Stephens P, Edkins S, Tsui WW, Chan AS, et al. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res. 2002;62:6451\u20135.","journal-title":"Cancer Res"},{"key":"322_CR5","first-page":"1454","volume":"63","author":"ET Kimura","year":"2003","unstructured":"Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003;63:1454\u20137.","journal-title":"Cancer Res"},{"key":"322_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jnci\/95.8.625","volume":"95","author":"Y Cohen","year":"2003","unstructured":"Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst. 2003;95:625\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"322_CR7","doi-asserted-by":"crossref","first-page":"237428951877572","DOI":"10.1177\/2374289518775722","volume":"5","author":"S Segura","year":"2018","unstructured":"Segura S, Ramos-Rivera G, Suhrland M. Educational case: endocrine neoplasm: medullary thyroid carcinoma. Acad Pathol. 2018;5:2374289518775722.","journal-title":"Acad Pathol"},{"key":"322_CR8","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","volume":"83","author":"SA Hundahl","year":"1998","unstructured":"Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]. Cancer. 1998;83:2638\u201348.","journal-title":"Cancer"},{"key":"322_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1677\/erc.1.0978","volume":"12","author":"M Xing","year":"2005","unstructured":"Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer. 2005;12:245\u201362.","journal-title":"Endocr Relat Cancer"},{"key":"322_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","volume":"361","author":"SI Sherman","year":"2003","unstructured":"Sherman SI. Thyroid carcinoma. Lancet. 2003;361:501\u201311.","journal-title":"Lancet"},{"key":"322_CR11","doi-asserted-by":"crossref","unstructured":"Ragazzi M, Ciarrocchi A, Sancisi V, Gandolfi G, Bisagni A, Piana S. Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the Most aggressive thyroid Cancer. Int J Endocrinol. 2014.","DOI":"10.1155\/2014\/790834"},{"key":"322_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1535-6108(03)00189-2","volume":"4","author":"DA Tuveson","year":"2003","unstructured":"Tuveson DA, Weber BL, Herlyn M. BRAF as a potential therapeutic target in melanoma and other malignancies. Cancer Cell. 2003;4:95\u20138.","journal-title":"Cancer Cell"},{"key":"322_CR13","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1038\/sj.onc.1206706","volume":"22","author":"P Soares","year":"2003","unstructured":"Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R, Sobrinho-Simoes M. BRAF mutations and RET\/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene. 2003;22:4578\u201380.","journal-title":"Oncogene"},{"key":"322_CR14","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-04-3314","volume":"65","author":"N Mitsutake","year":"2005","unstructured":"Mitsutake N, Knauf JA, Mitsutake S, Mesa C Jr, Zhang L, Fagin JA. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells. Cancer Res. 2005;65:2465\u201373.","journal-title":"Cancer Res"},{"key":"322_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nature13298","volume":"511","author":"A Viros","year":"2014","unstructured":"Viros A, Sanchez-Laorden B, Pedersen M, Furney SJ, Rae J, Hogan K, Ejiama S, Girotti MR, Cook M, Dhomen N, Marais R. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53. Nature. 2014;511:478\u201382.","journal-title":"Nature"},{"key":"322_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1088\/0952-4746\/31\/3\/R01","volume":"31","author":"SF Mobbs","year":"2011","unstructured":"Mobbs SF, Muirhead CR, Harrison JD. Risks from ionising radiation: an HPA viewpoint paper for Safegrounds. J Radiol Prot. 2011;31:289\u2013307.","journal-title":"J Radiol Prot"},{"key":"322_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep15809","volume":"5","author":"RK Kim","year":"2015","unstructured":"Kim RK, Kim MJ, Seong KM, Kaushik N, Suh Y, Yoo KC, Cui YH, Jin YW, Nam SY, Lee SJ. Beneficial effects of low dose radiation in response to the oncogenic KRAS induced cellular transformation. Sci Rep. 2015;5:15809.","journal-title":"Sci Rep"},{"key":"322_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep43361","volume":"7","author":"N Kaushik","year":"2017","unstructured":"Kaushik N, Kim MJ, Kim RK, Kumar Kaushik N, Seong KM, Nam SY, Lee SJ. Low-dose radiation decreases tumor progression via the inhibition of the JAK1\/STAT3 signaling axis in breast cancer cell lines. Sci Rep. 2017;7:43361.","journal-title":"Sci Rep"},{"key":"322_CR19","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1210\/jc.2006-2707","volume":"92","author":"C Durante","year":"2007","unstructured":"Durante C, Puxeddu E, Ferretti E, Morisi R, Moretti S, Bruno R, Barbi F, Avenia N, Scipioni A, Verrienti A, et al. BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab. 2007;92:2840\u20133.","journal-title":"J Clin Endocrinol Metab"},{"key":"322_CR20","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1210\/er.2007-0007","volume":"28","author":"M Xing","year":"2007","unstructured":"Xing M. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev. 2007;28:742\u201362.","journal-title":"Endocr Rev"},{"key":"322_CR21","doi-asserted-by":"crossref","unstructured":"American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, et al: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19:1167\u20131214.","DOI":"10.1089\/thy.2009.0110"},{"key":"322_CR22","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schlumberger M. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"322_CR23","doi-asserted-by":"publisher","first-page":"13144","DOI":"10.1073\/pnas.240336397","volume":"97","author":"M Pasca di Magliano","year":"2000","unstructured":"Pasca di Magliano M, Di Lauro R, Zannini M. Pax8 has a key role in thyroid cell differentiation. Proc Natl Acad Sci U S A. 2000;97:13144\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"322_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrendo.2014.186","volume":"11","author":"LP Fernandez","year":"2015","unstructured":"Fernandez LP, Lopez-Marquez A, Santisteban P. Thyroid transcription factors in development, differentiation and disease. Nat Rev Endocrinol. 2015;11:29\u201342.","journal-title":"Nat Rev Endocrinol"},{"key":"322_CR25","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1128\/MCB.19.3.2051","volume":"19","author":"M Ohno","year":"1999","unstructured":"Ohno M, Zannini M, Levy O, Carrasco N, di Lauro R. The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium\/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol Cell Biol. 1999;19:2051\u201360.","journal-title":"Mol Cell Biol"},{"key":"322_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/379458a0","volume":"379","author":"G Dai","year":"1996","unstructured":"Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature. 1996;379:458\u201360.","journal-title":"Nature"},{"key":"322_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159:676\u201390.","journal-title":"Cell"},{"key":"322_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ab.2009.08.038","volume":"396","author":"F Waltz","year":"2010","unstructured":"Waltz F, Pillette L, Ambroise Y. A nonradioactive iodide uptake assay for sodium iodide symporter function. Anal Biochem. 2010;396:91\u20135.","journal-title":"Anal Biochem"},{"key":"322_CR29","doi-asserted-by":"crossref","unstructured":"Sewell W, Reeb A, Lin RY. An orthotopic mouse model of anaplastic thyroid carcinoma. J Vis Exp. 2013.","DOI":"10.3791\/50097"},{"key":"322_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4137\/CIN.S7226","volume":"10","author":"G Shin","year":"2011","unstructured":"Shin G, Kang TW, Yang S, Baek SJ, Jeong YS, Kim SY. GENT: gene expression database of normal and tumor tissues. Cancer Inform. 2011;10:149\u201357.","journal-title":"Cancer Inform"},{"key":"322_CR31","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Cancer Genome Atlas Research N, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM. The Cancer genome atlas pan-Cancer analysis project. Nat Genet. 2013;45:1113\u201320.","journal-title":"Nat Genet"},{"key":"322_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jss.2012.08.053","volume":"182","author":"DA Kleiman","year":"2013","unstructured":"Kleiman DA, Buitrago D, Crowley MJ, Beninato T, Veach AJ, Zanzonico PB, Jin M, Fahey TJ, Zarnegar R. Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing. J Surg Res. 2013;182:85\u201393.","journal-title":"J Surg Res"},{"key":"322_CR33","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1158\/1078-0432.CCR-06-1753","volume":"13","author":"DX Liu","year":"2007","unstructured":"Liu DX, Hu SY, Hou P, Jiang D, Condouris S, Xing MZ. Suppression of BRAF\/MEK\/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant. Clin Cancer Res. 2007;13:1341\u20139.","journal-title":"Clin Cancer Res"},{"key":"322_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJM199801293380506","volume":"338","author":"MJ Schlumberger","year":"1998","unstructured":"Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998;338:297\u2013306.","journal-title":"N Engl J Med"},{"key":"322_CR35","doi-asserted-by":"publisher","first-page":"e0156658","DOI":"10.1371\/journal.pone.0156658","volume":"11","author":"F Rosignolo","year":"2016","unstructured":"Rosignolo F, Sponziello M, Durante C, Puppin C, Mio C, Baldan F, Di Loreto C, Russo D, Filetti S, Damante G. Expression of PAX8 target genes in papillary thyroid carcinoma. PLoS One. 2016;11:e0156658.","journal-title":"PLoS One"},{"key":"322_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15\u201320.","journal-title":"Cell"},{"key":"322_CR37","doi-asserted-by":"publisher","first-page":"D146","DOI":"10.1093\/nar\/gku1104","volume":"43","author":"N Wong","year":"2015","unstructured":"Wong N, Wang XW. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2015;43:D146\u201352.","journal-title":"Nucleic Acids Res"},{"key":"322_CR38","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1371\/journal.pbio.0020363","volume":"2","author":"B John","year":"2004","unstructured":"John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol. 2004;2:1862\u201379.","journal-title":"PLoS Biol"},{"key":"322_CR39","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature09267","volume":"466","author":"HL Guo","year":"2010","unstructured":"Guo HL, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466:835\u2013U866.","journal-title":"Nature"},{"key":"322_CR40","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2217\/fon.13.83","volume":"9","author":"GB Lesinski","year":"2013","unstructured":"Lesinski GB. The potential for targeting the STAT3 pathway as a novel therapy for melanoma. Future Oncol. 2013;9:925\u20137.","journal-title":"Future Oncol"},{"key":"322_CR41","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.semcdb.2008.07.010","volume":"19","author":"BA Croker","year":"2008","unstructured":"Croker BA, Kiu H, Nicholson SE. SOCS regulation of the JAK\/STAT signalling pathway. Semin Cell Dev Biol. 2008;19:414\u201322.","journal-title":"Semin Cell Dev Biol"},{"key":"322_CR42","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1158\/0008-5472.CAN-09-0727","volume":"69","author":"JC Ricarte-Filho","year":"2009","unstructured":"Ricarte-Filho JC, Ryder M, Chitale DA, Rivera M, Heguy A, Ladanyi M, Janakiraman M, Solit D, Knauf JA, Tuttle RM, et al. Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct Pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res. 2009;69:4885\u201393.","journal-title":"Cancer Res"},{"key":"322_CR43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1677\/erc.1.01119","volume":"13","author":"G Riesco-Eizaguirre","year":"2006","unstructured":"Riesco-Eizaguirre G, Gutierrez-Martinez P, Garcia-Cabezas MA, Nistal M, Santisteban P. The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+\/I- targeting to the membrane. Endocr Relat Cancer. 2006;13:257\u201369.","journal-title":"Endocr Relat Cancer"},{"key":"322_CR44","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.1038\/sj.onc.1208822","volume":"24","author":"TJ Giordano","year":"2005","unstructured":"Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, Zhu ZW, Ciampi R, Roh M, Shedden K, et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET\/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene. 2005;24:6646\u201356.","journal-title":"Oncogene"},{"key":"322_CR45","doi-asserted-by":"crossref","unstructured":"Di Palma T, Filippone MG, Pierantoni GM, Fusco A, Soddu S, Zannini M. Pax8 has a critical role in epithelial cell survival and proliferation. Cell Death Dis. 2013;4.","DOI":"10.1038\/cddis.2013.262"},{"key":"322_CR46","doi-asserted-by":"publisher","first-page":"15462","DOI":"10.1073\/pnas.242328999","volume":"99","author":"MP Postiglione","year":"2002","unstructured":"Postiglione MP, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M, Marians RC, Davies TF, Zannini MS, De Felice M, Di Lauro R. Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci U S A. 2002;99:15462\u20137.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-019-0322-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12964-019-0322-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-019-0322-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T19:12:24Z","timestamp":1581534744000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-019-0322-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["322"],"URL":"https:\/\/doi.org\/10.1186\/s12964-019-0322-x","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"1 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human patient samples were recovered from the archives of the Department of Pathology at the Korea Cancer Center Hospital. The consent medical records of the patients corresponding to these cases were reviewed. This study was permitted by the Institutional Review Board of the Korea Cancer Center Hospital. In case of mice studies, animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the Center for Laboratory Animal Sciences, the Medical Research Coordinating Center, and the HYU Industry-University Cooperation Foundation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"On the behalf of all co-authors, I provide the consent for publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"12"}}